OFM

Omega Fund Management Portfolio holdings

AUM $154M
This Quarter Return
-0.47%
1 Year Return
-32.78%
3 Year Return
+82.35%
5 Year Return
+29.08%
10 Year Return
+90.46%
AUM
$370M
AUM Growth
+$370M
Cap. Flow
+$15M
Cap. Flow %
4.07%
Top 10 Hldgs %
94.7%
Holding
17
New
2
Increased
2
Reduced
4
Closed
1
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
REPL icon
1
Replimune Group
REPL
$422M
$122M 33.11% 5,344,971
MORF
2
DELISTED
Morphic Holding, Inc. Common Stock
MORF
$81.4M 22.02% 2,977,832 +2,250 +0.1% +$61.5K
GOSS icon
3
Gossamer Bio
GOSS
$562M
$41.2M 11.15% 3,320,608
IMUX icon
4
Immunic
IMUX
$80.9M
$33.2M 8.98% 1,788,160 +416,666 +30% +$7.74M
ARQT icon
5
Arcutis Biotherapeutics
ARQT
$1.86B
$19.3M 5.22% 658,908 -185,772 -22% -$5.44M
CMPI
6
DELISTED
Checkmate Pharmaceuticals, Inc. Common Stock
CMPI
$15.4M 4.16% +1,335,050 New +$15.4M
PRTK
7
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$14.1M 3.81% 2,600,410 -2,329 -0.1% -$12.6K
ALPN
8
DELISTED
Alpine Immune Sciences, Inc. Common Stock
ALPN
$11.3M 3.06% +1,284,900 New +$11.3M
EPIX icon
9
ESSA Pharma
EPIX
$11.4M
$6.1M 1.65% 912,693 -584,755 -39% -$3.91M
CDTX icon
10
Cidara Therapeutics
CDTX
$1.66B
$5.72M 1.55% 2,005,249
TRVI icon
11
Trevi Therapeutics
TRVI
$883M
$5.55M 1.5% 1,375,907
FGEN icon
12
FibroGen
FGEN
$47.8M
$5.37M 1.45% 130,646
JNCE
13
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
$2.73M 0.74% 334,965 -195,000 -37% -$1.59M
OBSV
14
DELISTED
ObsEva SA Ordinary Shares
OBSV
$2.48M 0.67% 999,364
PRVL
15
DELISTED
Prevail Therapeutics Inc. Common Stock
PRVL
$1.91M 0.52% 187,538
PVLA
16
Palvella Therapeutics, Inc. Common Stock
PVLA
$599M
$1.55M 0.42% 750,741
BEAM icon
17
Beam Therapeutics
BEAM
$1.66B
-302,821 Closed -$8.48M